Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Ablation of ORMDL3 impairs adipose tissue thermogenesis and insulin sensitivity by increasing ceramide generation

Song Y., Zan W., Qin L., Han S., Ye L., Wang M.

Animal Study on Type 2 Diabetes, published in Mol Metab (2022) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Mol Metab (2022)
Reported sample size
—
Source database
Europe PMC
PMID
34954108
PMCID
PMC8762460
DOI
10.1016/j.molmet.2021.101423
Citations
18

Abstract (original English)

Objective Genome-wide association studies identified ORMDL3 as an obesity-related gene, and its expression was negatively correlated with body mass index. However, the precise biological roles of ORMDL3 in obesity and lipid metabolism remain uncharacterized. Here, we investigate the function of ORMDL3 in adipose tissue thermogenesis and high fat diet (HFD)-induced insulin resistance. Methods Ormdl3-deficient (Ormdl3 -/- ) mice were employed to delineate the function of ORMDL3 in brown adipose tissue (BAT) thermogenesis and white adipose tissue (WAT) browning. Glucose and lipid homeostasis in Ormdl3 -/- mice fed a HFD were assessed. The lipid composition in adipose tissue was evaluated by mass spectrometry. Primary adipocytes in culture were used to determine the mechanism by which ORMDL3 regulates white adipose browning. Results BAT thermogenesis and WAT browning were significantly impaired in Ormdl3 -/- mice upon cold exposure or administration with the β3 adrenergic agonist. In addition, compared to WT mice, Ormdl3 -/- mice displayed increased weight gain and insulin resistance in response to HFD. The induction of uncoupling protein 1 (UCP1), a marker of thermogenesis, was attenuated in primary adipocytes derived from Ormdl3 -/- mice. Importantly, ceramide levels were elevated in the adipose tissue of Ormdl3 -/- mice. In addition, the reduction in thermogenesis and increase i

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsMice, KnockoutMiceInsulin ResistanceCeramidesMembrane ProteinsEnergy MetabolismThermogenesisAdipose Tissue, BrownAdipose Tissue, White

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research